GlassScriptPhysician profile
Ibrahim Elkattawy
NPI 1861980138
$8,768.74
in general payments reported to CMS, 2019-2025
22 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,590 · 2023: $2,800 · 2024: $919 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,954 · Travel and Lodging: $1,137 · Long Term Medical Supply Or Device Loan: $87.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,953.79 |
| Travel and Lodging | $1,137.25 |
| Long Term Medical Supply Or Device Loan | $87.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $3,164.11 | 2022-2023 | |
| Paragon 28, INC. | $1,550.27 | 2022-2024 | Precision Mis Bunion |
| Treace Medical Concepts, INC. | $713.71 | 2022-2023 | |
| Stryker Corporation | $694.68 | 2023-2025 | Citrefix, Augment Injectable, Flexband |
| Arthrex, INC. | $640.20 | 2023 | |
| Kerecis Limited | $543.14 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $466.00 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paratek Pharmaceuticals, INC. | $383.66 | 2022-2025 | Nuzyra |
| Convatec INC. | $118.09 | 2023-2024 | |
| Organogenesis INC. | $113.57 | 2023-2024 | Puraply |
| Musculoskeletal Transplant Foundation INC. | $94.53 | 2023 | |
| Voom Medical Devices, INC. | $55.96 | 2024 | Revcon |
| Orthofix Medical, INC. | $33.27 | 2025 | Physio-Stim |
| International Rehabilitative Sciences, INC | $31.61 | 2024 | Rs 4i Plus Sequential Stimulator |
| Highridge Medical LLC | $30.10 | 2024 | Biomet Ebi Bone Healing System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hartmann USA, INC. | $25.88 | 2025 | Zetuvit Plus 10x10 P10 |
| Ibsa Pharma INC. | $21.86 | 2023 | Tirosint, Licart |
| Curonix LLC | $20.43 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Zimvie INC. | $18.77 | 2022 | |
| Averitas Pharma INC. | $16.60 | 2025 | Qutenza |
| Zimmer Biomet Holdings, INC. | $16.53 | 2022 | |
| Smith+Nephew, INC. | $15.77 | 2023 | Regranex, Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ibrahim Elkattawy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.